Bayer Group in Leverkusen: The third appeals process in the USA is lost
Photo: Getty Images
The agrochemical and pharmaceutical company Bayer has also suffered a defeat in the third of its US appeals proceedings due to alleged cancer risks of the weed killer glyphosate. The responsible court in San Francisco confirmed a ruling on Monday that Bayer must be liable for cancers of plaintiffs Alberta and Alva Pilliod. In 2019, a jury first sentenced the group to pay damages and fines of around two billion dollars to the couple. The amount was later reduced to $ 86.7 million.
A spokesman for Bayer said the company respected the court's decision but disagreed with it.
The judgment is not supported by the evidence at the trial or by applicable law.
The group is exploring its options for a re-examination of the case.
Bayer acquired US seed manufacturer Monsanto in 2018 for more than 60 billion euros.
Since then, Bayer has been confronted with numerous other glyphosate lawsuits in the United States, which the Group would like to settle with a settlement.
So far, only three cases have been finally negotiated in courts, and the Dax group lost all three processes.
Bayer has not had any success in appointment procedures either.
The Leverkusen-based company has high hopes that one of the judgments by the US Supreme Court will be overturned.
In the event that the Supreme Court does not want to deal with the glyphosate case or decides against Bayer, the group recently set up additional provisions of $ 4.5 billion.
Bayer had previously set aside more than $ 11 billion for a settlement package to settle US lawsuits.
hba / dpa